Related Experiment Videos
Sleep EEG changes after zolpidem in mice.
Caroline Kopp1, Uwe Rudolph, Irene Tobler
1Institute of Pharmacology and Toxicology, University of Zurich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
Neuroreport
|September 17, 2004
Summary
Zolpidem promotes sleep by acting on alpha1GABAA receptors. Studies in mutant mice show these receptors are crucial for zolpidem
Area of Science:
- Neuroscience
- Pharmacology
- Sleep Medicine
Background:
- Zolpidem is a common hypnotic medication.
- It selectively binds to alpha1-containing GABAA receptors.
- The precise role of these receptors in zolpidem's effects is not fully understood.
Purpose of the Study:
- To investigate the specific role of alpha1GABAA receptors in mediating the sleep-promoting and electroencephalographic (EEG) effects of zolpidem.
- To compare the effects of zolpidem in wild-type mice and mice with zolpidem-insensitive alpha1GABAA receptors.
Main Methods:
- Utilized mutant mice with altered alpha1GABAA receptors and wild-type controls.
- Administered zolpidem at different doses (5 and 10 mg/kg).
- Recorded and analyzed non-REM sleep EEG power spectral density.
Main Results:
- Zolpidem promoted sleep in both wild-type and mutant mice.
- In wild-type mice, zolpidem significantly reduced non-REM sleep EEG power across broad frequencies at 5 and 10 mg/kg.
- In mutant mice, EEG power reduction was dose-dependent, occurring only at the highest dose and restricted to specific low frequencies.
Conclusions:
- The effects of zolpidem on mouse sleep EEG are primarily mediated by alpha1GABAA receptors.
- These effects are distinct from those typically observed with benzodiazepines.
- Alpha1GABAA receptors are key targets for zolpidem's hypnotic actions.